The introduction of nicotinamide as a nicotine replacement in e-cigarette and smokeless products and solutions represents an important regulatory problem for your FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is known to act as a sedative at substantial dosages6. The claims made by Nicotine River, ECBlend, together with ot